Socioeconomic impact and burden of hypertension in the Philippines projected in 2050
- PMID: 36229530
- DOI: 10.1038/s41440-022-01052-6
Socioeconomic impact and burden of hypertension in the Philippines projected in 2050
Abstract
Hypertension has remained the number one cause of cardiovascular death in the Philippines for over three (3) decades. Despite this finding, the burden accounted for by hypertension is investigated to a lesser extent. We performed this study to determine the socioeconomic impact of hypertension in the Philippines, and it was projected in the next 30 years. We gathered primary data through interviews, Labor Force Survey (N = 806), and secondary data from various government published reports. The cost of illness (COI) was calculated using the direct morbidity and mortality costs. The impact (% of respondents) of uncontrolled hypertension on productivity at work showed the following; four (4) days missing work (72%) and ten (10) days lost of productivity (63%). The impact (% of respondents) of uncontrolled hypertension on productivity at home showed the following: six (6) days of household suspended (66%), eleven (11) days reduced household work (78%), and five (5) days affected social activity (60%). The productivity loss of premature mortality accounts for 17% of the total economic burden in 2020 and will increase to 20% by 2050. In 2020, 70% of the total economic burden was accounted for direct & indirect care. At its present value, the economic cost of hypertension is expected to increase from US$1 billion in 2020 to US$1.9 billion by 2050. The socioeconomic impact of uncontrolled hypertension in the Philippines was enormous, challenging, and overwhelming for the next 30 years.
Keywords: Burden of disease; Cost of illness; Hypertension; Projection; Socioeconomic impact.
© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
References
-
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–80. - DOI
-
- Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37. - DOI
-
- Galson SW, Staniffer JW, Hertz JT, Temu G, Thielman N, Gafaar T, et al. The burden of hypertension in the emergency department and linkage tto care: a prospective cohort study in Tanzania. PLoS One 2019;14: https://doi.org/10.1371/journal.pone.0211287 . eCollection 2019.
-
- Hird TR, Zomer E, Owen AJ, Magliano DJ, Liew D, Ademi Z. Productivity burden of hypertension in Australia. Hypertension. 2019;73:777–84. - DOI
-
- Kothavale A, Pun P, Yadav S The burden of hypertension and unmet need for hypertension care among men aged 15-54 years: a population-based cross-sectional study in India. J Biosoc Sci 20211-22. https://doi.org/10.1017/S0021932021000481 .
MeSH terms
LinkOut - more resources
Full Text Sources
Medical